<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34813820</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2742</ISSN><JournalIssue CitedMedium="Internet"><Volume>84</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Journal of infection</Title><ISOAbbreviation>J Infect</ISOAbbreviation></Journal><ArticleTitle>Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies.</ArticleTitle><Pagination><StartPage>158</StartPage><EndPage>170</EndPage><MedlinePgn>158-170</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jinf.2021.11.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0163-4453(21)00555-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Data on the long-term impact of SARS-CoV-2 infection in children and young people (CYP) are conflicting. We assessed evidence on long-term post-COVID symptoms in CYP examining prevalence, risk factors, type and duration.</AbstractText><AbstractText Label="METHODS">Systematic search of published and unpublished literature using 13 online databases between 01/12/2019 and 31/07/2021. Eligible studies reported CYP &#x2264;19 years with confirmed or probable SARS-CoV-2 with any symptoms persisting beyond acute illness. Random effects meta-analyses estimated pooled risk difference in symptom prevalence (controlled studies only) and pooled prevalence (uncontrolled studies also included). Meta-regression examined study characteristics hypothesised to be associated with symptom prevalence. Prospectively registered: CRD42021233153.</AbstractText><AbstractText Label="FINDINGS">Twenty two of 3357 unique studies were eligible, including 23,141 CYP. Median duration of follow-up was 125 days (IQR 99-231). Pooled risk difference in post-COVID cases compared to controls (5 studies) were significantly higher for cognitive difficulties (3% (95% CI 1, 4)), headache (5% (1, 8)), loss of smell (8%, (2, 15)), sore throat (2% (1, 2)) and sore eyes (2% (1, 3)) but not abdominal pain, cough, fatigue, myalgia, insomnia, diarrhoea, fever, dizziness or dyspnoea. Pooled prevalence of symptoms in post-COVID participants in 17 studies ranged from 15% (diarrhoea) to 47% (fatigue). Age was associated with higher prevalence of all symptoms except cough. Higher study quality was associated with lower prevalence of all symptoms, except loss of smell and cognitive symptoms.</AbstractText><AbstractText Label="INTERPRETATION">The frequency of the majority of reported persistent symptoms was similar in SARS-CoV-2 positive cases and controls. This systematic review and meta-analysis highlights the critical importance of a control group in studies on CYP post SARS-CoV-2 infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Behnood</LastName><ForeName>S A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafran</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>S D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>A X D</ForeName><Initials>AXD</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Mahoney</LastName><ForeName>L L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Diabetes Research Centre, University of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephenson</LastName><ForeName>T J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladhani</LastName><ForeName>S N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Immunisation and Countermeasures Division, Public Health England Colindale, United Kingdom; Paediatric Infectious Disease, St. George's Hospital London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Stavola</LastName><ForeName>B L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viner</LastName><ForeName>R M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swann</LastName><ForeName>O V</ForeName><Initials>OV</Initials><AffiliationInfo><Affiliation>Department of Child Life and Health, University of Edinburgh, United Kingdom; Royal Hospital for Children, Glasgow, United Kingdom. Electronic address: Olivia.Swann@ed.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect</MedlineTA><NlmUniqueID>7908424</NlmUniqueID><ISSNLinking>0163-4453</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Infect. 2023 Sep;87(3):280-281. doi: 10.1016/j.jinf.2023.07.004</RefSource><PMID Version="1">37442375</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Infect. 2023 Dec;87(6):576-578. doi: 10.1016/j.jinf.2023.09.005</RefSource><PMID Version="1">37739272</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Children and young people</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Paediatric</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest SAB, RS, SDB, AXDZ, LLO, SNL, BLDS, RMV and OVS have no conflicts of interest. TJS is the Chair of the Health Research Authority for England who reimburse his university for his time. He is not paid personally. He has recused himself from research studies in which he is personally involved and which require ethical approval from the HRA.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>23</Day><Hour>20</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34813820</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pii">S0163-4453(21)00555-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Perego E., Callard F., Stras L., Melville-J&#xf3;hannesson B., Pope R., Alwan N.A. Why the patient-made term 'long COVID' is needed [version 1; peer review: awaiting peer review] Wellcome Open Res. 2020:224.</Citation></Reference><Reference><Citation>Callard F., P E. How and why patients made long COVID. Soc Sci Med. 2021;268</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers. J Med Virol. 2021;93(5):2555&#x2013;2556.</Citation><ArticleIdList><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview | COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Guidance | NICE [Internet]. Nice.org.uk. 2021 [cited 07 June 2021]. Available from: https://www.nice.org.uk/guidance/NG188.</Citation></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson H. Long-term effects children with long COVID. New Sci. 2021;245(3323):10&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7927578</ArticleId><ArticleId IdType="pubmed">33686318</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A'Court C., Buxton M., Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Healthcare Workers [Internet]. Centers for Disease Control and Prevention. 2021 [cited 11 June 2021]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.</Citation></Reference><Reference><Citation>Yong S.J. Long-haul COVID-19: putative pathophysiology, risk factors, and treatments. Preprintsorg. 2020;53(10):737&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Living with Covid19 Second review [Internet]. NIHR Evidence. 2021 [cited 02 October 2021]. Available from: https://evidence.nihr.ac.uk/themedreview/living-with-covid19-second-review/ (accessed 02 October 2021).</Citation></Reference><Reference><Citation>Venturelli S., Benatti S.V., Casati M., et al. Surviving COVID-19 in bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect. 2021;149:e32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child. 2021;106(5):429&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pubmed">33262177</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter M.J., Shankar-Hari M., Tibby S.M. Paediatric inflammatory multisystem syndrome temporally-associated with SARS-CoV-2 infection: an overview. Intensive Care Med. 2021;47(1):90&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556601</ArticleId><ArticleId IdType="pubmed">33057783</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies P., Evans C., Kanthimathinathan H.K., et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health. 2020;4(9):669&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347350</ArticleId><ArticleId IdType="pubmed">32653054</ArticleId></ArticleIdList></Reference><Reference><Citation>Swann O.V., Holden K.A., Turtle L., et al. Clinical characteristics of children and young people admitted to hospital with COVID-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020;370:m3249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7488201</ArticleId><ArticleId IdType="pubmed">32960186</ArticleId></ArticleIdList></Reference><Reference><Citation>Waseem M., Shariff M.A., Tay E.T., et al. Multisystem inflammatory syndrome in children. J Emerg Med. 2021;S0736-4679(21) 00652-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8445772</ArticleId><ArticleId IdType="pubmed">34538678</ArticleId></ArticleIdList></Reference><Reference><Citation>Viner R.M., Whittaker E. Kawasaki-like disease: emerging complication during the COVID-19 pandemic. Lancet. 2020;395(10239):1741&#x2013;1743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220168</ArticleId><ArticleId IdType="pubmed">32410759</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste L., Van Paemel R., Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr. 2021;180(7):2019&#x2013;2034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7890544</ArticleId><ArticleId IdType="pubmed">33599835</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., for the Gemelli Against COVID-19 Post-Acute Care Study Group Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. 2021;11(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Peny V., Valind A. Re: case reports and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 2021;110(4):1372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013181</ArticleId><ArticleId IdType="pubmed">33459399</ArticleId></ArticleIdList></Reference><Reference><Citation>Viner R., Clark C., Taylor S., et al. Longitudinal risk factors for persistent fatigue in adolescents. Arch Pediatr Adolesc Med. 2008;162(5):469&#x2013;475.</Citation><ArticleIdList><ArticleId IdType="pubmed">18458194</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Pittet L.F., Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Dis J. 2021;40(12):e482&#x2013;e487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Shamseer L., Clarke M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>Stang A. Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Moola S., Munn Z., Tufanaru C., Aromataris E., Sears K., Sfetcu R., Currie M., Lisy K., Qureshi R., Mattis P., Mu P. In: JBI Manual for Evidence Synthesis. JBI. Aromataris E., Munn Z., editors. 2020. Chapter 7: Systematic reviews of etiology and risk. Appendix 7.4 Critical appraisal checklist for case reports.</Citation></Reference><Reference><Citation>Moola S., Munn Z., Tufanaru C., Aromataris E., Sears K., Sfetcu R., Currie M., Lisy K., Qureshi R., Mattis P., Mu P. In: JBI Manual for Evidence Synthesis. JBI. Aromataris E., Munn Z., editors. 2020. Chapter 7: Systematic reviews of etiology and risk. Appendix 7.5 Critical appraisal checklist for analytical cross-sectional studies.</Citation></Reference><Reference><Citation>Hunter J.P., Saratzis A., Sutton A.J., Boucher R.H., Sayers R.D., Bown M.J. In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias. J Clin Epidemiol. 2014;67(8):897&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pubmed">24794697</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankenburg J., Wekenborg M.K., Reichert J., et al. Mental health of adolescents in the pandemic: long-COVID19 or long-pandemic syndrome? medRxiv. 2021 2021.05.11.21257037.</Citation></Reference><Reference><Citation>Brackel C.L.H., Lap C.R., Buddingh E.P., et al. Pediatric long-COVID: an overlooked phenomenon? Pediatr Pulmonol. 2021;56(8):2495&#x2013;2502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242715</ArticleId><ArticleId IdType="pubmed">34102037</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Pujol F.E., Munblit D., Mcfarland S., Simpson F. Clinical characteristics, activity levels and mental health problems in children with long COVID: a survey of 510 children. Preprints Org. 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., De Rose C., et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110(7):2208&#x2013;2211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevinsky J.R., Tao G., Lavery A.M., et al. Late conditions diagnosed 1-4 months following an initial COVID-19 encounter: a matched cohort study using inpatient and outpatient administrative data - United States, March 1-June 30, 2020. Clin Infect Dis Off Publ Infect Dis Soc Am. 2021;73(Supplement_1):S5&#x2013;S16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135331</ArticleId><ArticleId IdType="pubmed">33909072</ArticleId></ArticleIdList></Reference><Reference><Citation>Denina M., Pruccoli G., Scolfaro C., et al. Sequelae of COVID-19 in hospitalized children: a 4-months follow-up. Pediatr Infect Dis J. 2020;39(12):e458&#x2013;e4e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33003103</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller F., Nguyen V., Navaratnam A.M., et al. Prevalence of persistent symptoms in children during the COVID-19 pandemic: evidence from a household cohort study in England and Wales. medrxiv. 2021 2021.05.28.21257602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9645448</ArticleId><ArticleId IdType="pubmed">36375098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson J.F. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 2020;110(3):914&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogueira Lopez J., Grasa C., Calvo C., Garcia Lopez-Hortelano M. Long-term symptoms of COVID-19 in children. Acta Paediatr. 2021;110(7):2282&#x2013;2283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251185</ArticleId><ArticleId IdType="pubmed">33745209</ArticleId></ArticleIdList></Reference><Reference><Citation>Leftin Dobkin S.C. Proceedings of the American Journal of Respiratory and Critical Care Medicine Conference: American Thoracic Society International Conference. Vol. 203. 2021. Respiratory findings in children post-COVID-19 infection. ATS.</Citation></Reference><Reference><Citation>Knoke L., Schlegtendal A., Maier C., Eitner L., L&#xfc;cke T., Brinkmann F. More complaints than findings - long-term pulmonary function in children and adolescents after COVID-19. medRxiv. 2021 2021.06.22.21259273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9081758</ArticleId><ArticleId IdType="pubmed">35547532</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E., Sudre C.H., Canas L.S., et al. Lancet Child Adolesc Health. 2021. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Epub ahead of print 3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P., et al. Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur Respir J. 2021;01 doi: 10.1183/13993003.01341-2021. Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M.S., Kristiansen M.F., Hanusson K.D., et al. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin Infect Dis. 2020 ciaa1792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T., Ulyte A., Puhan M.A., Kriemler S. Long-term symptoms after SARS-CoV-2 infection in school children: population-based cohort with 6-months follow-up. medrxiv. 2021;326(9):869. Short Report.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusetsky Y., Meytel I., Mokoyan Z., Fisenko A., Babayan A., Malyavina U. Smell status in children infected with SARS-CoV-2. Laryngoscope. 2021;131(8):E2475&#x2013;E2E80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013292</ArticleId><ArticleId IdType="pubmed">33443298</ArticleId></ArticleIdList></Reference><Reference><Citation>Say D., Crawford N., McNab S., Wurzel D., Steer A., Tosif S. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health. 2021;5(6):e22&#x2013;ee3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8057863</ArticleId><ArticleId IdType="pubmed">33891880</ArticleId></ArticleIdList></Reference><Reference><Citation>Sante GD, Buensenso D, De Rose C, et al. Immune profile of children with post-acute sequelae of SARS-CoV-2 infection (long COVID) medRxiv. 2021;05.07.21256539</Citation></Reference><Reference><Citation>Smane L., Pucuka Z., Roge I., Pavare J., Stars I. Persistent clinical features in paediatric patients after SARS-CoV-2 virological recovery: a retrospective population-based cohort study from a single centre in Latvia. BMJ Paediatr Open. 2020;4(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778738</ArticleId><ArticleId IdType="pubmed">34192185</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterky E., Olsson-&#xc5;kefeldt S., Hertting O., et al. Persistent symptoms in Swedish children after hospitalisation due to COVID-19. Acta Paediatr. 2021;110(9):2578&#x2013;2580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444740</ArticleId><ArticleId IdType="pubmed">34157167</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavala M., Ireland G., Amin-Chowdhury Z., Ramsay M.E., Ladhani S.N. Acute and persistent symptoms in children with PCR-confirmed SARS-CoV-2 infection compared to test-negative children in England: active, prospective, national surveillance. Clin Infect Dis Off Publ Infect Dis Soc Am. 2021:ciab991.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8767867</ArticleId><ArticleId IdType="pubmed">34849658</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Shafran R., De Stavola B., et al.  Long COVID - the physical and mental health of children and non-hospitalised young people 3 months after SARS-CoV-2 infection; a national matched cohort study (The CLoCk) Study. Res Sq. 2021 [Internet]. 2021 [cited 2021 Nov 29]. Available from:  https://www.researchsquare.com/article/rs-798316/v1.</Citation></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., et al. Characterising long-term covid-19: a rapid living systematic review. medrxiv. 2020</Citation></Reference><Reference><Citation>Salamanna F., Veronesi F., Martini L., Landini M.P., Fini M. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. a systematic review of the current data. Front Med. 2021;8:392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta E.M., Spallone A., Rodriguez-Barradas M.C., El Sahly H.M., Atmar R.L., Kulkarni P.A. Postacute COVID-19: an overview and approach to classification. Open Forum Infect Dis. 2020;7(12):ofaa509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M.F., Cotler J., Jason L.A. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue Biomed Health Behav. 2020;8(2):61&#x2013;69.</Citation></Reference><Reference><Citation>Carlos C.R., Gerardo M.M., Jaime O.G., Isauro G.H.L., Dios A.P.J. Prevalence of neurological manifestations in COVID-19 and their association with mortality. Neurol Perspect. 2021;1(1):11&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934699</ArticleId><ArticleId IdType="pubmed">38620629</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Fat L., Scholes S., Boniface S., Mindell J., Stewart-Brown S. Evaluating and establishing national norms for mental wellbeing using the short warwick-edinburgh mental well-being scale (SWEMWBS): findings from the health survey for England. Qual Life Res. 2017;26(5):1129&#x2013;1144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5376387</ArticleId><ArticleId IdType="pubmed">27853963</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella M., Chalder T. Measuring fatigue in clinical and community settings. J Psychosom Res. 2010;69(1):17&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">20630259</ArticleId></ArticleIdList></Reference><Reference><Citation>Straus S.E., Tosato G., Armstrong G., et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med. 1985;102(1):7&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">2578268</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021 01410768211032850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Thein H.H., Butler T., Krahn M., et al. The effect of hepatitis C virus infection on health-related quality of life in prisoners. J Urban Health. 2006;83(2):275&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2527173</ArticleId><ArticleId IdType="pubmed">16736376</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>